Literature DB >> 7402369

Intestinal secretion of digoxin in the rat. Augmentation by feeding activated charcoal.

J H Caldwell, P B Caldwell, J W Murphy, C W Beachler.   

Abstract

Secretion of tritium-labeled digoxin was studied in rats using noneverted gut sacs, in ligated and perfused intestinal preparations in bile duct ligated rats, and by measuring 4 day fecal excretion of total radioactivity in bile duct ligated rats. Serosal to mucosal transfer was proportional to substrate concentration in vitro. In ligated intestinal loops radioactivity was concentrated in the lumen relative to serum. In perfused intestinal preparations the fraction of dose increased with time and was similar over a 100-fold range of doses. Bile duct ligated rats excreted 13.4 +/- 5.8 (S.D.) % of parenterally administered label in 4 day stool collections. Bile duct ligated rats treated with p.o. activated charcoal excreted significantly more radioactivity (33.4 +/- 7.9%). The results suggest that net nonbiliary intestinal secretion of digoxin and metabolites can be augmented by intraluminal binding. A role for this phenomenon in accounting for some effects of diseases and drug interactions is suggested.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7402369     DOI: 10.1007/bf00499157

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  22 in total

1.  Pharmacokinetics of digoxin in normal subjects after intravenous bolus and infusion doses.

Authors:  J R Koup; D J Greenblatt; W J Jusko; T W Smith; J Koch-Weser
Journal:  J Pharmacokinet Biopharm       Date:  1975-06

2.  Dose-independent pharmacokinetics of digoxin in humans.

Authors:  H R Ochs; D J Greenblatt; G Bodem; J S Harmatz
Journal:  Am Heart J       Date:  1978-10       Impact factor: 4.749

3.  [Intestinal absorption of cardiac glycosides in vitro and in vivo].

Authors:  W Forth; E Furukawa; W Rummel
Journal:  Naunyn Schmiedebergs Arch Exp Pathol Pharmakol       Date:  1969

4.  Tritiated digoxin excretion of patients following renal transplantation.

Authors:  J E Doherty; W J Flanigan; W H Perkins
Journal:  Circulation       Date:  1968-05       Impact factor: 29.690

5.  Absorption rates of some cardiac glycosides and portal blood flow.

Authors:  A Haass; H Lüllmann; T Peters
Journal:  Eur J Pharmacol       Date:  1972-09       Impact factor: 4.432

6.  Tritiated digoxin. XIV. Enterohepatic circulation, absorption, and excretion studies in human volunteers.

Authors:  J E Doherty; W J Flanigan; M L Murphy; R T Bulloch; G L Dalrymple; O W Beard; W H Perkins
Journal:  Circulation       Date:  1970-11       Impact factor: 29.690

7.  The distribution and excretion of tritiated substances in experimental animals following the administration of digoxin-3H.

Authors:  C E Harrison; R O Brandenburg; P A Ongley; A L Orvis; C A Owen
Journal:  J Lab Clin Med       Date:  1966-05

8.  Reduction of absorption of digoxin, phenytoin and aspirin by activated charcoal in man.

Authors:  P J Neuvonen; S M Elfving; E Elonen
Journal:  Eur J Clin Pharmacol       Date:  1978-05-31       Impact factor: 2.953

9.  Marked decline in serum digoxin concentration during an episode of severe diarrhea.

Authors:  A J Kolibash; W G Kramer; R H Reuning; J H Caldwell
Journal:  Am Heart J       Date:  1977-12       Impact factor: 4.749

10.  Interruption of the enterohepatic circulation of digitoxin by cholestyramine. I. Protection against lethal digitoxin intoxication.

Authors:  J H Caldwell; N J Greenberger
Journal:  J Clin Invest       Date:  1971-12       Impact factor: 14.808

View more
  7 in total

1.  Role of repeated oral doses of activated charcoal in clinical toxicology.

Authors:  S M Pond
Journal:  Med Toxicol       Date:  1986 Jan-Feb

2.  Interactions with digoxin: more problems.

Authors:  C F George
Journal:  Br Med J (Clin Res Ed)       Date:  1982-01-30

Review 3.  Clinical pharmacokinetics of oral activated charcoal in acute intoxications.

Authors:  P J Neuvonen
Journal:  Clin Pharmacokinet       Date:  1982 Nov-Dec       Impact factor: 6.447

4.  Pharmacokinetics of digoxin cross-reacting substances in patients with acute yellow Oleander (Thevetia peruviana) poisoning, including the effect of activated charcoal.

Authors:  Darren M Roberts; Emma Southcott; Julia M Potter; Michael S Roberts; Michael Eddleston; Nick A Buckley
Journal:  Ther Drug Monit       Date:  2006-12       Impact factor: 3.681

5.  The influence of cholestyramine on the elimination of tenoxicam and piroxicam.

Authors:  T W Guentert; R Defoin; H Mosberg
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953

6.  Cutaneous absorption of Oleander: Fact or fiction.

Authors:  S Senthilkumaran; S Saravanakumar; P Thirumalaikolundusubramanian
Journal:  J Emerg Trauma Shock       Date:  2009-01

Review 7.  Pharmacokinetic considerations in clinical toxicology: clinical applications.

Authors:  Darren M Roberts; Nick A Buckley
Journal:  Clin Pharmacokinet       Date:  2007       Impact factor: 6.447

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.